Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Ovarian Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Contact: Study coordinator (Liantao Li, M.D., Ph.D.) · liliantao@xzhmu.edu.cn · +86-516-85582530
Contact: Study coordinator (Xin Ding, M.D., Ph.D.) · dingxin81@163.com · +86-516-83355832

Study leads

Junnian Zheng, M.D., Ph.D.
Study Director
The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University
Longzhen Zhang, M.D., Ph.D.
Principal Investigator
The Affiliated Hospital of Xuzhou Medical University
Gang Wang, Ph.D.
Principal Investigator
Xuzhou Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer

Ovarian Cancer

Abroad (travel likely)RecruitingPHASE2

Chicago, United States · Kelowna, Canada

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Metastatic Colorectal Cancer · Metastatic Pancreatic Cancer · Metastatic Ovarian Cancer

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Breast Cancer · Endometrial Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orlando, United States · Boston, United States

Intensification Treatment of Ovarian Cancer by PIPAC

Advanced Epithelial Ovarian Cancer · Peritoneal Carcinomatosis

Abroad (travel likely)RecruitingPHASE2

Balashikha, Russia